Methods for treatment of COVID-19 syndrome
Abstract:
The invention relates generally to methods for treating and modulating the severity of COVID-19 syndrome. The methods comprise administering a therapeutically effective amount of a pharmaceutical composition to a human patient, the composition comprising secretin and a pharmaceutically acceptable carrier.
Public/Granted literature
Information query
Patent Agency Ranking
0/0